Pennsylvania Allergy & Asthma Society

  • Home
    • About PAAA >
      • Mission and Bylaws
      • Officers and Committees
      • Board of Regents Minutes
      • Legislation and Advocacy
      • Membership
      • Corporate Partners >
        • Corporate Partners
        • Support Opportunities
  • Events
    • Virtual Education Programs
    • Annual Meeting >
      • Exhibitor Information
    • Past Event Information >
      • Photo Gallery
  • TRAINEES/TRAINING
  • PAAA Education & Research Fund
    • PAERF Contributors
    • 2023 Research/Education Grants
  • For the Public
    • What is An Allergist?
    • Common Allergic Diseases
    • Pennsylvania Allergens
  • Member Login
  • NIAID-funded Research
  • Home
    • About PAAA >
      • Mission and Bylaws
      • Officers and Committees
      • Board of Regents Minutes
      • Legislation and Advocacy
      • Membership
      • Corporate Partners >
        • Corporate Partners
        • Support Opportunities
  • Events
    • Virtual Education Programs
    • Annual Meeting >
      • Exhibitor Information
    • Past Event Information >
      • Photo Gallery
  • TRAINEES/TRAINING
  • PAAA Education & Research Fund
    • PAERF Contributors
    • 2023 Research/Education Grants
  • For the Public
    • What is An Allergist?
    • Common Allergic Diseases
    • Pennsylvania Allergens
  • Member Login
  • NIAID-funded Research
Picture
DBV Technologies
25 Deforest Avenue, Suite 203
Summit, NJ 07901

www.dbv-technologies.com

About DBV Technologies
DBV Technologies is a global biopharmaceutical company that’s developing investigational epicutaneous immunotherapy (EPIT™) technology to treat millions of people suffering from life-threatening food allergies and other immunological disorders. Starting with peanut, we are investigating food allergy treatments that are designed to potentially reduce the risk of unpredictable, life-threatening reactions due to accidental exposure.

Representative
Joseph M Chalil, MD, MBA, FACHE
Senior Director, Clinical Development & Medical Affairs
joseph.chalil@dbv-technologies.com

Jeff Germani
Director, Clinical Development & Medical Affairs
jeff.germani@dbv-technologies.com

Todd D. Green, MD, FAAAAI, FACAAI
Vice President, Clinical Development & Medical Affairs
todd.green@dbv-technologies.com

Katharine Bee, PhD
Senior Director, Medical Services & Communications
katharine.bee@dbv-technologies.com


Social Media
​
https://twitter.com/dbvtechnologies
https://www.linkedin.com/company/dbv-technologies
https://www.facebook.com/DBVTechnologies/
Representatives will be available to meet with attendees at the following times:
Friday, June 25
7:30 a.m. - 7:50 a.m.
10:15 a.m. - 10:45 a.m.
Saturday, June 26
7:30 a.m. - 7:50 a.m.
9:30 a.m. - 10:00 a.m.
11:45 a.m. - 12:15 p.m.
MEET WITH REPRESENTATIVES
Resources
2021 DBV Clinical Program Overview
2021 DBV Clinical Trial Information Flyer

DBV Infographic: An Investigational Approach to Peanut Allergy
RETURN TO EXHIBIT GALLERY
Picture

Corporate Sponsor

Picture
Pennsylvania Allergy and Asthma Association.  All Rights Reserved.
 400 Winding Creek Blvd, Mechanicsburg, PA 17050
Phone: (833) 770-1543 |
paaa@paallergy.org
© 2017, Pennsylvania Allergy & Asthma Association. All rights are reserved.

Contact Us | Privacy Policy | Terms of Use | Sitemap